Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 11/20 | 0.41 |
| ▸ | CRY2 | Q49AN0 | 4/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | USP19 | O94966 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29296300 | 0.73 | MAPT (0.35) | — | |
| SCHEMBL29299316 | 0.73 | PIK3CD (0.30) | PIK3CD | |
| SCHEMBL20001263 | 0.70 | PER2 (0.46) | PER2CRY2 | |
| SCHEMBL20001284 | 0.66 | FPR1 (0.49) | PER2CRY2 | |
| SCHEMBL19988409 | 0.66 | POLB (0.40) | PER2CRY2 | |
| SCHEMBL2032257 | 0.64 | PIK3CD (0.64) | PER2CRY2PIK3CD | |
| SCHEMBL12776296 | 0.61 | GFER (0.55) | PIK3CDGFER | |
| SCHEMBL29296183 | 0.61 | — | — | |
| SCHEMBL22142088 | 0.60 | RIPK2 (0.31) | — | |
| SCHEMBL22142526 | 0.60 | RIPK2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | TP53, HRAS, KRAS | PER2 4282/4885CRY2 3132/4885PIK3CD 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.